Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-02-000705
Filing Date
2002-03-11
Accepted
2002-03-11 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 am202414001ag7.txt SC 13G/A 9398
  Complete submission text file 0000919574-02-000705.txt   11263
Mailing Address 2525 DUPONT DRIVE IRVINE CA 92612
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142466912
ALLERGAN SPECIALTY THERAPEUTICS INC (Subject) CIK: 0001049711 (see all company filings)

EIN.: 330779207 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-53925 | Film No.: 02572578
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 RADNOR CORP CENTER 100 MATSONFORD ROAD SUITE 520 RADNOR PA 19087
Business Address 5 RADNOR CORP CENTER 100 MATSONFORD ROAD SUITE 520 RADNOR PA 19087 6109640750
CONSTABLE LOURDE JOHN (Filed by) CIK: 0001060522 (see all company filings)